Markets
EW

Navidea (NAVB) Worth Watching: Stock Up 7.3% - Tale of the Tape

Navidea Biopharmaceuticals, Inc. ( NAVB ) was a big mover last session with its shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 34% in the past one-month time frame.

This biopharmaceutical company has seen 1 positive estimate revision in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday's rally can turn into more strength down the road.

Navidea currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Investors interested in the medical industry may consider other well-placed stocks like RTI Surgical Inc. ( RTIX ), Alphatec Holdings, Inc. ( ATEC ) and Edwards Lifesciences Corp. ( EW ). While RTIX and ATEC sport a Zacks Rank #1 (Strong Buy), EW carries the same Zacks Rank as Navidea.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

NAVIDEA BIOPHAR (NAVB): Free Stock Analysis Report

RTI SURGICAL (RTIX): Free Stock Analysis Report

ALPHATEC HLDGS (ATEC): Free Stock Analysis Report

EDWARDS LIFESCI (EW): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EW ATEC NAVB SRGA

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More